Ind-Swift Laboratories Limited Wins Arbitration Case Against PI Industries Limited
Ind-Swift Laboratories Limited has concluded arbitration proceedings with PI Industries Limited. The Arbitral Tribunal rejected all claims and counterclaims, resulting in zero financial impact on the company. The final order was passed on April 7, 2026.
The arbitration proceedings concluded with NIL financial impact on the company, indicating a low impact on its financial standing.
The company has won an arbitration case, with all claims rejected and no financial impact. This is a positive outcome.
Ind-Swift Laboratories Limited (ISLL) has received a final order from the Arbitral Tribunal constituted by the Mumbai Centre for International Arbitration (MCIA) concerning arbitration proceedings with M/s. PI Industries Limited. The tribunal, in its order dated April 7, 2026, rejected all claims made by PI Industries Limited as well as all counterclaims filed by Ind-Swift Laboratories Limited and others.
Consequently, the arbitration proceedings have been concluded with no financial impact on Ind-Swift Laboratories Limited. This outcome signifies the successful resolution of the legal dispute, with the company facing neither claims nor having to pay any compensation.
What to do with a filing like this
Ind-Swift Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Ind-Swift Laboratories Limited. Read the original for the full detail.